Treatment Pattern and Direct Cost of Biologics for Rheumatoid Arthritis Patients: A Real-World Analysis of Nationwide Japanese Claims Data.

被引：0
|
作者：
Sugiyama, Naonobu [1 ]
Murata, Tatsunori [2 ]
Morishima, Yosuke [1 ]
Fukuma, Yuri [1 ]
Shibasaki, Yoshiyuki [1 ]
Marshall, Lisa [3 ]
机构：
[1] Pfizer Japan Inc, RA & Inflammat Area Med Affairs Dept, Tokyo, Japan
[2] CRECON Res & Consulting Inc, Hlth Econ Res Grp, Tokyo, Japan
[3] Pfizer Inc, Inflammat Immunol Dis Grp, Collegeville, PA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2418
引用
收藏
页码：S1054 / S1055
页数：2
相关论文
共 50 条
  • [1] TREATMENT PATTERN AND DIRECT COST OF BIOLOGICS FOR RHEUMATOID ARTHRITIS (RA) PATIENTS: A REAL-WORLD ANALYSIS OF NATIONWIDE JAPANESE CLAIMS DATA
    Sugiyama, N.
    Murata, T.
    Morishima, Y.
    Fukuma, Y.
    Shibasaki, Y.
    Marshall, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 325 - 325
  • [2] Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data
    Sugiyama, Naonobu
    Kawahito, Yutaka
    Fujii, Takao
    Atsumi, Tatsuya
    Murata, Tatsunori
    Morishima, Yosuke
    Fukuma, Yuri
    [J]. CLINICAL THERAPEUTICS, 2016, 38 (06) : 1359 - 1375
  • [3] COST-EFFECTIVENESS OF BIOLOGICS FOR RHEUMATOID ARTHRITIS PATIENTS: A REAL-WORLD ANALYSIS OF NATIONWIDE JAPANESE CLAIMS DATA
    Sugiyama, N.
    Murata, T.
    Morishima, Y.
    Fukuma, Y.
    Shibasaki, Y.
    Bidad, C.
    Harnett, J.
    Marshall, L.
    Coindreau, J. L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 461 - 461
  • [4] Real-world retention rates of biologics in patients with rheumatoid arthritis
    Takami, Kenji
    Tsuji, Shigeyoshi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [5] Real-world retention rates of biologics in patients with rheumatoid arthritis
    Kenji Takami
    Shigeyoshi Tsuji
    [J]. Scientific Reports, 13
  • [6] REAL-WORLD COMORBIDITIES, TREATMENT PATTERN AND COST OF PATIENTS WITH ACROMEGALY IN POLAND BASED ON RETROSPECTIVE ANALYSIS OF ADMINISTRATIVE CLAIMS DATA
    Sliwczynski, A.
    Brzozowska, M.
    Labenda, A.
    Orlewska, K.
    Milkowski, M.
    Orlewska, E.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A682 - A683
  • [7] Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany-a health insurance claims data analysis
    Fiehn, Christoph
    Zinke, Silke
    Haas, Jennifer S.
    Meise, Dominic
    Theil, Julia
    Gurrath, Margot
    Orzechowski, Hans-Dieter
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2023, 82 (09): : 739 - 753
  • [8] Estimation of direct cost of managing rheumatoid arthritis treatment to Pakistani patients using real-world follow-up data
    Naqvi, Atta Abbas
    Hassali, Mohamed Azmi
    Naqvi, Syed Baqir Shyum
    Kachela, Bharti
    Khan, Irfanullah
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (03) : 325 - 333
  • [9] RHEUMATOID ARTHRITIS: TREATMENT SEQUENCING IN GUIDELINES COMPARED TO REAL-WORLD EVIDENCE. A GERMAN CLAIMS DATA ANALYSIS
    Wilbertz, S.
    Gruppe, T.
    Bardenheuer, K.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A548 - A548
  • [10] REAL-WORLD UTILIZATION PATTERN OF BIOLOGICS IN RHEUMATOID ARTHRITIS: A POPULATION-BASED STUDY
    Liao, C. H.
    Wang, Y. C.
    Chen, J. J.
    Pwu, R. F.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A613 - A613
12345